Global High-Throughput Sequencing (HTS) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global High-Throughput Sequencing (HTS) Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Report Code: KNJ1408749 | No. of Pages: 104 | Category: Pharmaceuticals and Healthcare
Publisher: Maia Research | Date of Publish: Sep-2022
Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for High-Throughput Sequencing (HTS) estimated at in the year 2022, is projected to reach a revised size of by 2028, growing at a CAGR of during the forecast period 2022-2028.

The USA market for High-Throughput Sequencing (HTS) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for High-Throughput Sequencing (HTS) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for High-Throughput Sequencing (HTS) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key companies of High-Throughput Sequencing (HTS) include Illumina, Applied Biosystems (ABI), Roche (454), Helicos and LifeTechnologies, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the High-Throughput Sequencing (HTS) companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional High-Throughput Sequencing (HTS) market. Further, it explains the major drivers and regional dynamics of the global High-Throughput Sequencing (HTS) market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Illumina

Applied Biosystems (ABI)

Roche (454)

Helicos

LifeTechnologies

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

High-Throughput Sequencing (HTS) Segment by Type

Sequencing by Synthesis

Sequencing by Ligation

High-Throughput Sequencing (HTS) Segment by Application

Oncology

Hereditary Disease Detection

Life Science

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the High-Throughput Sequencing (HTS) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global High-Throughput Sequencing (HTS) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Sequencing by Synthesis

1.2.3 Sequencing by Ligation

1.3 Market by Application

1.3.1 Global High-Throughput Sequencing (HTS) Market Growth Rate by Application: 2017 VS 2021 VS 2028

1.3.2 Oncology

1.3.3 Hereditary Disease Detection

1.3.4 Life Science

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global High-Throughput Sequencing (HTS) Market Size (2017-2028)

2.2 High-Throughput Sequencing (HTS) Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.3 Global High-Throughput Sequencing (HTS) Market Size by Region (2017-2022)

2.4 Global High-Throughput Sequencing (HTS) Market Size Forecast by Region (2023-2028)

2.5 Global Top High-Throughput Sequencing (HTS) Countries Ranking by Market Size

3 High-Throughput Sequencing (HTS) Competitive by Company

3.1 Global High-Throughput Sequencing (HTS) Revenue by Players

3.1.1 Global High-Throughput Sequencing (HTS) Revenue by Players (2017-2022)

3.1.2 Global High-Throughput Sequencing (HTS) Market Share by Players (2017-2022)

3.2 Global High-Throughput Sequencing (HTS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Company Covered: Ranking by High-Throughput Sequencing (HTS) Revenue

3.4 Global High-Throughput Sequencing (HTS) Market Concentration Ratio

3.4.1 Global High-Throughput Sequencing (HTS) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by High-Throughput Sequencing (HTS) Revenue in 2021

3.5 Global High-Throughput Sequencing (HTS) Key Players Head office and Area Served

3.6 Key Players High-Throughput Sequencing (HTS) Product Solution and Service

3.7 Date of Enter into High-Throughput Sequencing (HTS) Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Global High-Throughput Sequencing (HTS) Breakdown Data by Type

4.1 Global High-Throughput Sequencing (HTS) Historic Revenue by Type (2017-2022)

4.2 Global High-Throughput Sequencing (HTS) Forecasted Revenue by Type (2023-2028)

5 Global High-Throughput Sequencing (HTS) Breakdown Data by Application

5.1 Global High-Throughput Sequencing (HTS) Historic Market Size by Application (2017-2022)

5.2 Global High-Throughput Sequencing (HTS) Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America High-Throughput Sequencing (HTS) Revenue by Company (2020-2022)

6.2 North America High-Throughput Sequencing (HTS) Revenue by Type (2017-2028)

6.3 North America High-Throughput Sequencing (HTS) Revenue by Application (2017-2028)

6.4 North America High-Throughput Sequencing (HTS) Revenue by Country (2017-2028)

6.4.1 U.S.

6.4.2 Canada

7 Europe

7.1 Europe High-Throughput Sequencing (HTS) Revenue by Company (2020-2022)

7.2 Europe High-Throughput Sequencing (HTS) Revenue by Type (2017-2028)

7.3 Europe High-Throughput Sequencing (HTS) Revenue by Application (2017-2028)

7.4 Europe High-Throughput Sequencing (HTS) Revenue by Country (2017-2028)

7.4.1 Germany

7.4.2 France

7.4.3 U.K.

7.4.4 Italy

7.4.5 Russia

8 Asia Pacific

8.1 Asia Pacific High-Throughput Sequencing (HTS) Revenue by Company (2020-2022)

8.2 Asia Pacific High-Throughput Sequencing (HTS) Revenue by Type (2017-2028)

8.3 Asia Pacific High-Throughput Sequencing (HTS) Revenue by Application (2017-2028)

8.4 Asia Pacific High-Throughput Sequencing (HTS) Revenue by Region (2017-2028)

8.4.1 China

8.4.2 Japan

8.4.3 South Korea

8.4.4 India

8.4.5 Australia

8.4.6 China Taiwan

8.4.7 Indonesia

8.4.8 Thailand

8.4.9 Malaysia

9 Latin America

9.1 Latin America High-Throughput Sequencing (HTS) Revenue by Company (2020-2022)

9.2 Latin America High-Throughput Sequencing (HTS) Revenue by Type (2017-2028)

9.3 Latin America High-Throughput Sequencing (HTS) Revenue by Application (2017-2028)

9.4 Latin America High-Throughput Sequencing (HTS) Revenue by Country (2017-2028)

9.4.1 Mexico

9.4.2 Brazil

9.4.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa High-Throughput Sequencing (HTS) Revenue by Company (2020-2022)

10.2 Middle East and Africa High-Throughput Sequencing (HTS) Revenue by Type (2017-2028)

10.3 Middle East and Africa High-Throughput Sequencing (HTS) Revenue by Application (2017-2028)

10.4 Middle East and Africa High-Throughput Sequencing (HTS) Revenue by Country (2017-2028)

10.4.1 Turkey

10.4.2 Saudi Arabia

10.4.3 UAE

11 Company Profiles

11.1 Illumina

11.1.1 Illumina Company Details

11.1.2 Illumina Business Overview

11.1.3 Illumina High-Throughput Sequencing (HTS) Products and Services

11.1.4 Illumina High-Throughput Sequencing (HTS) Revenue in High-Throughput Sequencing (HTS) Business (2017-2022)

11.1.5 Illumina High-Throughput Sequencing (HTS) SWOT Analysis

11.1.6 Illumina Recent Developments

11.2 Applied Biosystems (ABI)

11.2.1 Applied Biosystems (ABI) Company Details

11.2.2 Applied Biosystems (ABI) Business Overview

11.2.3 Applied Biosystems (ABI) High-Throughput Sequencing (HTS) Products and Services

11.2.4 Applied Biosystems (ABI) High-Throughput Sequencing (HTS) Revenue in High-Throughput Sequencing (HTS) Business (2017-2022)

11.2.5 Applied Biosystems (ABI) High-Throughput Sequencing (HTS) SWOT Analysis

11.2.6 Applied Biosystems (ABI) Recent Developments

11.3 Roche (454)

11.3.1 Roche (454) Company Details

11.3.2 Roche (454) Business Overview

11.3.3 Roche (454) High-Throughput Sequencing (HTS) Products and Services

11.3.4 Roche (454) High-Throughput Sequencing (HTS) Revenue in High-Throughput Sequencing (HTS) Business (2017-2022)

11.3.5 Roche (454) High-Throughput Sequencing (HTS) SWOT Analysis

11.3.6 Roche (454) Recent Developments

11.4 Helicos

11.4.1 Helicos Company Details

11.4.2 Helicos Business Overview

11.4.3 Helicos High-Throughput Sequencing (HTS) Products and Services

11.4.4 Helicos High-Throughput Sequencing (HTS) Revenue in High-Throughput Sequencing (HTS) Business (2017-2022)

11.4.5 Helicos High-Throughput Sequencing (HTS) SWOT Analysis

11.4.6 Helicos Recent Developments

11.5 LifeTechnologies

11.5.1 LifeTechnologies Company Details

11.5.2 LifeTechnologies Business Overview

11.5.3 LifeTechnologies High-Throughput Sequencing (HTS) Products and Services

11.5.4 LifeTechnologies High-Throughput Sequencing (HTS) Revenue in High-Throughput Sequencing (HTS) Business (2017-2022)

11.5.5 LifeTechnologies High-Throughput Sequencing (HTS) SWOT Analysis

11.5.6 LifeTechnologies Recent Developments

12 High-Throughput Sequencing (HTS) Market Dynamics

12.1 High-Throughput Sequencing (HTS) Market Trends

12.2 High-Throughput Sequencing (HTS) Market Drivers

12.3 High-Throughput Sequencing (HTS) Market Challenges

12.4 High-Throughput Sequencing (HTS) Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com